223 related articles for article (PubMed ID: 22783565)
1. Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients.
de Albuquerque A; Kubisch I; Ernst D; Breier G; Stamminger G; Fersis N; Stölzel U; Boese-Landgraf J; Eichler A; Kaul S
Clin Lab; 2012; 58(5-6):373-84. PubMed ID: 22783565
[TBL] [Abstract][Full Text] [Related]
2. Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study.
de Albuquerque A; Kubisch I; Breier G; Stamminger G; Fersis N; Eichler A; Kaul S; Stölzel U
Oncology; 2012; 82(1):3-10. PubMed ID: 22270149
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma.
Uen YH; Lin SR; Wu CH; Hsieh JS; Lu CY; Yu FJ; Huang TJ; Wang JY
Clin Chim Acta; 2006 May; 367(1-2):55-61. PubMed ID: 16403482
[TBL] [Abstract][Full Text] [Related]
4. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
[TBL] [Abstract][Full Text] [Related]
5. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
6. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
[TBL] [Abstract][Full Text] [Related]
7. Comparison of three distinct methods for the detection of circulating tumor cells in colorectal cancer patients.
Gervasoni A; Sandri MT; Nascimbeni R; Zorzino L; Cassatella MC; Baglioni L; Panigara S; Gervasi M; Di Lorenzo D; Parolini O
Oncol Rep; 2011 Jun; 25(6):1669-703. PubMed ID: 21455578
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of a colorimetric membrane-array method for the detection of circulating tumor cells in the peripheral blood of Taiwanese patients with colorectal cancer.
Wang JY; Yeh CS; Chen YF; Wu CH; Hsieh JS; Huang TJ; Huang SY; Lin SR
Int J Mol Med; 2006 May; 17(5):737-47. PubMed ID: 16596255
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of enrichment and detection of circulating tumor cells in NSCLC patients with immunomagnetic beads].
Huang TH; Wang Z; Li Q; Li FR; Qi H; Zhou HX
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):676-80. PubMed ID: 18246797
[TBL] [Abstract][Full Text] [Related]
10. Multimarker Analysis of Circulating Tumor Cells in Peripheral Blood of Metastatic Breast Cancer Patients: A Step Forward in Personalized Medicine.
de Albuquerque A; Kaul S; Breier G; Krabisch P; Fersis N
Breast Care (Basel); 2012 Feb; 7(1):7-12. PubMed ID: 22553466
[TBL] [Abstract][Full Text] [Related]
11. Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies.
Bonmassar L; Fossile E; Scoppola A; Graziani G; Prete SP; Formica V; Cappelletti D; De Vecchis L; Cardillo A; Concolino F; D'Atri S; Balduzzi A; Torino F; Caporaso P; Greiner JW; Bonmassar E; Roselli M; Aquino A
Anticancer Res; 2010 Nov; 30(11):4721-30. PubMed ID: 21115931
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cells in patients with breast cancer: monitoring chemotherapy success.
Ušiaková Z; Mikulová V; Pintérová D; Brychta M; Valchář J; Kubecová M; Tesařová P; Bobek V; Kološtová K
In Vivo; 2014; 28(4):605-14. PubMed ID: 24982230
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells.
Hampton R; Walker M; Marshall J; Juhl H
Oncogene; 2002 Nov; 21(51):7817-23. PubMed ID: 12420218
[TBL] [Abstract][Full Text] [Related]
14. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
[TBL] [Abstract][Full Text] [Related]
15. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood.
Tong X; Yang L; Lang JC; Zborowski M; Chalmers JJ
Cytometry B Clin Cytom; 2007 Sep; 72(5):310-23. PubMed ID: 17205568
[TBL] [Abstract][Full Text] [Related]
16. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.
Sieuwerts AM; Mostert B; Bolt-de Vries J; Peeters D; de Jongh FE; Stouthard JM; Dirix LY; van Dam PA; Van Galen A; de Weerd V; Kraan J; van der Spoel P; Ramírez-Moreno R; van Deurzen CH; Smid M; Yu JX; Jiang J; Wang Y; Gratama JW; Sleijfer S; Foekens JA; Martens JW
Clin Cancer Res; 2011 Jun; 17(11):3600-18. PubMed ID: 21505063
[TBL] [Abstract][Full Text] [Related]
17. Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction.
de Cremoux P; Extra JM; Denis MG; Pierga JY; Bourstyn E; Nos C; Clough KB; Boudou E; Martin EC; Müller A; Pouillart P; Magdelénat H
Clin Cancer Res; 2000 Aug; 6(8):3117-22. PubMed ID: 10955792
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.
Mostert B; Kraan J; Bolt-de Vries J; van der Spoel P; Sieuwerts AM; Schutte M; Timmermans AM; Foekens R; Martens JW; Gratama JW; Foekens JA; Sleijfer S
Breast Cancer Res Treat; 2011 May; 127(1):33-41. PubMed ID: 20379845
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.
Reinholz MM; Nibbe A; Jonart LM; Kitzmann K; Suman VJ; Ingle JN; Houghton R; Zehentner B; Roche PC; Lingle WL
Clin Cancer Res; 2005 May; 11(10):3722-32. PubMed ID: 15897569
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
